| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 09.02.
| The Zacks Analyst Blog Highlights: Western Union, Mylan, Valeant Pharmaceuticals, Sanofi and Pfizer | | 34 | PR Newswire |
| CHICAGO, Feb. 9, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...
Mehr lesen zu:
The Zacks Analyst Blog Highlights: Western Union, Mylan, Valeant Pharmaceuticals, Sanofi and Pfizer | |
| 08.02.
| Valeant Pharmaceuticals to Announce 2011 Fourth Quarter and Full Year Results on February 27, 2012 | | 9 | PR Newswire |
| MISSISSAUGA, Ontario, Feb. 8, 2012 /PRNewswire/ --Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet...
Mehr lesen zu:
Valeant Pharmaceuticals to Announce 2011 Fourth Quarter and Full Year Results on February 27, 2012 | |
| 08.02.
| Mylan purchases two dermatological products from Valeant | | 1 | Pharma Bus Review |
| 07.02.
| Valeant Pharmaceuticals International Has Returned 30.0% Since SmarTrend Recommendation | | - | SmarTrend |
| 06.02.
| Valeant Completes Divestiture Of Generic Dermatology Products To Mylan | | 35 | AFX News |
| CANONSBURG (dpa-AFX) - Valeant Pharmaceuticals International, Inc. (VRX,
VRX.TO) on Monday said it has completed the divestiture of 1 percent clindamycin
and 5 percent benzoyl peroxide gel...
Mehr lesen zu:
Valeant Completes Divestiture Of Generic Dermatology Products To Mylan | |
| 06.02.
| Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan | | 9 | PR Newswire |
| MISSISSAUGA, Ontario, Feb. 6, 2012 /PRNewswire/ --Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that it has completed the divestiture of1% clindamycin and 5%...
Mehr lesen zu:
Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan | |
| 06.02.
| Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant | | 10 | PR Newswire |
| PITTSBURGH, Feb. 6, 2012 /PRNewswire/ --Mylan Inc. (Nasdaq: MYL) today announced that it has successfully completed the acquisition of two dermatological products from Valeant...
Mehr lesen zu:
Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant | |
| 02.02.
| 2012 Economic Outlook - Report Highlights Valeant Pharmaceuticals Int (USA) and The Dow Chemical Company | | 11 | MarketWire |
| HONG KONG -- (Marketwire) -- 02/02/12 -- Today, www.BrightonMarkets.com announced new reports highlighting Valeant Pharmaceuticals Int (USA) (NYSE: VRX) and The Dow Chemical Company (NYSE: DOW). Gain...
Mehr lesen zu:
2012 Economic Outlook - Report Highlights Valeant Pharmaceuticals Int (USA) and The Dow Chemical Company | |
| 02.02.
| Valeant takes over Probiotica in Brazil | | 1 | Pharma Bus Review |
| 01.02.
| UPDATE 1-Valeant buys Brazil's Probiotica for $85 mln | | 1 | Reuters.com |
| 01.02.
| Valeant buys Brazilian food supplement maker | | 2 | Financial Post |
| 01.02.
| Valeant Pharmaceuticals Acquires Probiotica in Brazil for R$150M | | - | Benzinga.com |
| 01.02.
| Valeant Pharmaceuticals Acquires Probiotica in Brazil | | 70 | PR Newswire |
| MISSISSAUGA, Ontario, Feb.1, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that Valeant has acquired Probiotica Laboratorios Ltda., a leader...
Mehr lesen zu:
Valeant Pharmaceuticals Acquires Probiotica in Brazil | |
| 31.01.
| Valeant Withdraws ISTA Offer | | 1 | Zacks |
| 31.01.
| Valeant Pharmaceuticals International Shares Up 25.8% Since SmarTrend's Buy Recommendation | | - | SmarTrend |
| 30.01.
| Valeant Pharma ends bid to acquire Ista | | - | Yahoo-USA |
| 30.01.
| Valeant pulls bid for ISTA Pharmaceuticals | | 1 | Financial Post |
| 30.01.
| Valeant withdraws offer for ISTA Pharmaceuticals valued at US$7.50 per share | | 1 | Yahoo-CAN |
| 30.01.
| Valeant Pulls Ista Pharma Takeout Bid | | - | The Street |
| 30.01.
| Valeant Pharma scraps offer for ISTA Pharma | | 1 | MarketWatch |
